Presented by faculty from the University of Nebraska Medical Center and The University of Texas M. D. Anderson Cancer Center, this conference will provide cutting-edge information on clinically-relevant developments in the field including techniques and innovative uses of existing techniques, prognostic markers, targeted therapies, and diagnostic approaches.
CONFERENCE OBJECTIVES At the conclusion of the conference, the participant should be able to:
Describe recent developments in the diagnosis, classification, and molecular biology of hematological malignancies.
Recognize the impact of new developments on targeted therapy.
Implement current best practices for diagnosis, classification, and detection of prognostic markers.
